JavaScript is disabled. Please enable to continue!

Mobile search icon
BioPharma Services >> CDMO >> Eurofins Alphora

Eurofins CDMO Alphora

Sidebar Image

Eurofins CDMO Alphora: A full service contract research, development and manufacturing organization (CDMO) for complex, small molecule active pharmaceutical ingredients (APIs), oral drug products, solid state R&D and biologics

 

 

Eurofins CDMO Alphora – Comprehensive Drug Development Under One Roof

Located in Mississauga, Ontario, Canada, Eurofins CDMO Alphora is part of the global Eurofins CDMO network, delivering integrated solutions for small molecule and biologic drug substances and drug products—all under one roof.

Since 2003, our FDA, Health Canada, and Japan PMDA-inspected facility has been a trusted partner for pharmaceutical and biotech companies worldwide. With over 250 skilled professionals, we provide end-to-end support from preclinical development through commercial manufacturing, accelerating timelines and ensuring quality at every stage.

Our Capabilities

Small Molecules

  • API & HPAPI Development and GMP Manufacturing:  kilo lab scale: 1L to 50L; Pilot plant scale:  2x200 L, 4x 500L, 2x2000 L 
  • Oral Drug Product Development & Manufacturing
  • API Solid-State R&D (Polymorph Screening, Salt Selection, Fate & Purge Studies)

Biologics

  • Development & GMP Manufacture of Monoclonal Antibodies (mAbs), Proteins, and Antibody-Drug Conjugates (ADCs): 200L and 2000L (coming 2026)
  • Sterile Fill capabilities, up to 85,000 units/day (coming in 2026)

Why Choose Eurofins CDMO Alphora?

  • Integrated Services – Drug substance and drug product development under one roof.
  • Global Expertise – Seamless collaboration across Eurofins CDMO sites worldwide.
  • Regulatory Excellence – FDA, Health Canada, and PMDA inspected facility.
  • Proven Track Record – Supporting complex, niche programs from early development to commercialization for over two decades.
  • Specialized Expertise – Providing services in both small molecule and biologics 

Moving Medicine Forward

Our mission is simple: help pharmaceutical and biotech innovators overcome complexity and bring therapies to market faster. From IND-enabling studies to commercialization, we deliver science-driven solutions that simplify complexity and bring therapies to market faster, fulfilling our mission to move medicine forward.

Ready to accelerate your program?
Contact us today to learn how Eurofins CDMO Alphora can help you achieve your development goals.

Small Molecules – API Development & Manufacturing

API Development

API cGMP Manufacturing

API Commercialization Support

Solid State

Fate & Purge services

Impurity Synthesis

Process Optimization

Fast Track Program

Biologics Development & Manufacturing

Monoclonal Antibodies (mAbs)

Antibody Drug Conjugates (ADCs)

Drug Substance

Sterile Fill Finish